These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23799110)

  • 1. Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.
    Chen J; Tang H; Wu Z; Zhou C; Jiang T; Xue Y; Huang G; Yan D; Peng Z
    PLoS One; 2013; 8(6):e66524. PubMed ID: 23799110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
    Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
    Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis and association of RBBP6 with apoptosis in colon cancers.
    Dlamini Z; Rupnarain C; Naicker S; Hull R; Mbita Z
    J Mol Histol; 2016 Apr; 47(2):169-82. PubMed ID: 26905308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
    Guan WY; Zhao S; Luo YN
    Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.
    Lu S; Yan D; Wu Z; Jiang T; Chen J; Yuan L; Lin J; Peng Z; Tang H
    Oncol Rep; 2014 Apr; 31(4):1802-10. PubMed ID: 24573556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
    Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
    Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.
    Zhang M; Cui F; Lu S; Lu H; Jiang T; Chen J; Zhang X; Jin Y; Peng Z; Tang H
    Int J Clin Exp Pathol; 2014; 7(8):4867-76. PubMed ID: 25197357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer.
    Motadi LR; Bhoola KD; Dlamini Z
    Immunobiology; 2011 Oct; 216(10):1065-73. PubMed ID: 21676486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics analysis of gastric cancer stem cells.
    Morisaki T; Yashiro M; Kakehashi A; Inagaki A; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Sakurai K; Kubo N; Muguruma K; Ohira M; Wanibuchi H; Hirakawa K
    PLoS One; 2014; 9(11):e110736. PubMed ID: 25379943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.
    Liu F; Ye P; Bi T; Teng L; Xiang C; Wang H; Li Y; Jin K; Mou X
    Hepatogastroenterology; 2014 May; 61(131):652-9. PubMed ID: 26176052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-regulation of the RBBP6 isoform 3/DWNN in human cancers.
    Mbita Z; Meyer M; Skepu A; Hosie M; Rees J; Dlamini Z
    Mol Cell Biochem; 2012 Mar; 362(1-2):249-62. PubMed ID: 22139301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
    Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.
    Xiao C; Wu G; Zhou Z; Zhang X; Wang Y; Song G; Ding E; Sun X; Zhong L; Li S; Weng J; Zhu Z; Chen J; Wang X
    Cell Death Dis; 2019 Nov; 10(11):833. PubMed ID: 31685801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
    Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC
    PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
    Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
    Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death.
    Moela P; Choene MM; Motadi LR
    Immunobiology; 2014 Aug; 219(8):593-601. PubMed ID: 24703106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.